STAT3, a member of the Signal Transducer and Activator of Transcription (STAT) family, has attracted wide attention as a target for GBM treatment given its role in multiple cellular processes including proliferation, survival, and migration[22,23]. This evidence concerns the gene SOAT1 and glioblastoma.